A Phase I Trial of a LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine (Ag85B-ESAT6)
Clinical trial NCT00440544 · TERMINATED
Trial details
- NCT number
- NCT00440544
- Sponsor
- St George's, University of London
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2007-11-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.